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Abstract 
Recent structure analyses of αB-crystallin have proposed some models of the 
N-terminal domain and the manner of oligomerization, whereas the effects of the 
significantly high content of Pro residues at the N-terminal domain remain unclear.   
We report the properties of a novel P39R mutant of αB-crystallin.   The content of 
α-helix was increased, and the molecular size of the P39R mutant was larger than that of 
wild-type αB-crystallin.   A slight loss of chaperone-like activity was observed using 
alcohol dehydrogenase (ADH), while a significant increase was detected by insulin 
assay.   The Pro residue at the N-terminal domain of αB-crystallin is important for 




small heat shock protein, molecular chaperone, quaternary assembly, protein 
aggregation, secondary structure, cataract 
 
Abbreviations: 
ADH, alcohol dehydrogenase; sHSP, small heat shock protein, CD, circular dichroism; 
SAXS, small-angle X-ray scattering; DLS, dynamic light scattering 
 
Highlights:  
The P39R mutant αB-crystallin showed increased α-helix content. 
The molecular size of P39R mutant is larger than that of wild-type αB-crystallin. 
The P39R mutant displayed a slight loss of chaperone-like activity with ADH assay. 
The P39R mutant displayed an increase of the activity with denatured insulin. 




The transparency of eye lens cells is maintained by a highly abundant protein 
known as α-crystallin, which is composed of αA- and αB-crystallins [1].   Both 
proteins belong to the small heat shock protein (sHSP) family and function as molecular 
chaperones to prevent the aggregation of other proteins when exposed to certain types 
of stress [2].   Structural anomalies such as point mutations of α-crystallin genes [3] or 
racemization and isomerization of certain residues by UV irradiation [4,5] are known to 
cause human cataracts.   The expression of αB-crystallin is widespread in many 
tissues, including muscle and brain, and has been implicated in myopathies [6], 
Alexander disease [7], and Alzheimer’s disease [8].   For decades, researchers have 
attempted to describe the high-resolution structure of αB-crystallin, which is composed 
of a core structure conserved among all sHSPs that is referred to as the α-crystallin 
domain and highly flexible N- and C-terminal domains [9].   The crystal structures of 
truncated forms containing the α-crystallin domain and a portion of the C-terminal 
domain [10,11], together with solid-state NMR measurements of full-length 
αB-crystallin [12], have demonstrated that a stable homodimer is formed by the β-sheets 
of the α-crystallin domain.   However, the flexible N- and C-terminal domains yield 
diverse oligomerization states [13] and prevent the crystallization needed for 
high-resolution structure determination.   Recent studies of a quaternary assembly of 
αB-crystallin based on EM, solid-state NMR, and small-angle X-ray scattering (SAXS) 
analyses proposed homo-oligomer models of 24-meric assembly [14,15,16].   The 
models also provide reasonable explanations for the heterogeneity of αB-crystallin via 
the dynamic exchange of the dimer subassemblies to form larger oligomerizations such 
as 26 and 28-mer, and up to 36-mer proteins.   On the other hand, these models differ 
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significantly in terms of how contact is achieved between the N- and C-terminal 
domains and the neighboring subunit.   Therefore, further structure analyses will be 
needed to elucidate the detailed oligomerization mechanism of αB-crystallin. 
Several crystal structures of intact or artificially truncated proteins belonging to the 
sHSP family have been reported thus far.   Wheat HSP16.9 [17] and HSP16.5 from 
Methanococcus jannaschii (MjHSP16.5) [18] consist of 151 and 147 amino acids 
forming 12 and 24-meric homo-oligomers, respectively.   These sHSPs are thought to 
be highly homologous to 24-meric αB-crystallin composed of 175 amino acids in the 
monomeric structure.   Only in the crystal structure of wheat HSP16.9, almost the 
entire N- and C-terminal domain regions of the monomer have been identified.   The 
N-terminal domain of wheat HSP16.9 exhibits an α-helix-rich structure, which is in 
good agreement with the proposed model of the N-terminal domain of αB-crystallin [16].   
The amino acid sequence alignment of αB-crystallin with wheat HSP16.9 and 
MjHSP16.5 (Figure 1) revealed that the N-terminal domain of αB-crystallin contains 
significantly more Pro residues than do sHSPs.   The role played by the high Pro 
residue content at the N-terminal domain remains poorly understood.   However, the 
conformational rigidity of Pro residues would prevent the formation of stable secondary 
structures, and thereby could possible account for the flexible properties at the 
N-terminal domain.   It is noteworthy that the position of the Pro39 of αB-crystallin is 
conserved in MjHSP16.5 (Pro22), but replaced by Arg25 in wheat HSP16.9.   Pro22 
of MjHSP16.5 was not identified in the crystal structure due to disorder in the 
N-terminal domain, whereas residues 20-30 of wheat HSP16.9 form a continuous 
α-helix, which can be clearly observed in the crystal structure.   Thus, it would be 
reasonable to presume that Pro39 plays a key role in defining the structural stability of 
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the N-terminal domain, which could be expected to affect the oligomeric state and the 
functions of αB-crystallin. 
In this study, we investigated the properties of the oligomeric state and 
chaperone-like activity of the P39R mutant of αB-crystallin, a novel mutant designed 
based on protein structure information.   Comparisons with the properties of wild-type 
αB-crystallin revealed that the N-terminal domain is involved in multiple interactions 
that enable the formation of various oligomers and binding to denatured proteins, 
thereby enabling chaperone-like activities. 
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Materials and methods 
Expression and purification of recombinant wild-type and P39R mutant 
αB-crystallins 
Escherichia coli BL21(DE3)pLysS was transformed with the vector pET-23d 
containing human wild-type αB-crystallin cDNA (kind gift of Prof. L. Takemoto).   
The cells were grown at 37ºC, and expression was induced by 0.3 mM IPTG.   Then, 
the cell cultures were shaken further at 25ºC for 20 h.   The cells were harvested and 
resuspended in 20 mM Tris-HCl pH 8.0 (buffer A) and were disrupted by sonication.   
The soluble fraction was precipitated by 20% ammonium sulfate on ice, and the 
supernatant was precipitated by 50% ammonium sulfate.   The pellet containing 
wild-type αB-crystallin was resuspended and dialyzed with buffer A.   The cleared 
lysate was applied to a TOYOPEARL SuperQ-650S column (TOSOH) equilibrated with 
buffer A and eluted with a linear gradient of 0-0.5 M NaCl.   Wild-type αB-crystallin 
was eluted primarily in the flow-through fraction.   The fraction containing wild-type 
αB-crystallin was concentrated and loaded to a HiLoad 16/60 Superdex 200 column 
(GE healthcare) equilibrated with buffer A containing 150 mM NaCl and was eluted 
with the same buffer.   The purified protein was desalted and concentrated to 25 
mg/ml with buffer A for further experiments. 
The P39R mutation was introduced in the wild-type αB-crystallin cDNA using a 
KOD -Plus- Mutagenesis Kit (TOYOBO) and the mutagenic primer 
(5’-GAGTCTGATCTTTTCCGGACGTCTACTTCCCTG-3’ and 
5’-CAGGGAAGTAGACGTCCGGAAAAGATCAGACTC-3’).   The expression 
plasmids were transformed into E. coli Rosetta 2(DE3)pLysS and the cells were grown 
at 37ºC.   Expression was induced by 0.3 mM IPTG, and then the cell cultures were 
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shaken further at 25ºC for 20 h.   The cells were harvested, resuspended in buffer A, 
and disrupted by sonication.   The soluble fraction was applied to a TOYOPEARL 
SuperQ-650S column (TOSOH) equilibrated with buffer A and eluted with a linear 
gradient of 0-0.5 M NaCl.   The P39R mutant αB-crystallin was eluted primarily in 
the flow-through fraction.   Further purification steps on the gel filtration column were 
the same as those used for wild-type αB-crystallin. 
Circular dichroism (CD) spectroscopy 
The far-UV CD spectra of the proteins were recorded by a J-805 spectropolarimeter 
(JASCO) at 25ºC.   The protein concentration was 0.1 mg/ml in 0.1 mM buffer A.   
A quartz cell with a path length of 1 mm was used, and the reported spectra are the 
average of five accumulations.   The secondary structure contents of the proteins were 
analyzed using the program JWSSE-480. 
Size-exclusion chromatography 
The molecular size of the wild-type and the P39R mutant αB-crystallins was 
determined by size-exclusion chromatography on a 10 × 300 mm Sephacryl S-400 (GE 
healthcare) column, calibrated by the standard samples (GE healthcare) of thyroglobulin 
(669 kDa), ferritin (440 kDa), conalbumin (75 kDa), and ribonuclease A (13.7 kDa).   
The column was equilibrated with 50 mM Tris-HCl pH 8.0 containing 150 mM NaCl.   
The molecular size of the complexes of denatured proteins and αB-crystallins was 
determined by the same method. 
Dynamic light scattering 
Dynamic light scattering (DLS) measurements were carried out using a DynaPro 99 
instrument (Protein Solutions).   The samples were centrifuged to remove large 
aggregates and were then loaded onto a 12-µl sample cell (path length, 1.5 mm).   
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Data were analyzed using the program DYNAMICS version 5.26.56. 
Chaperone-like activity assays 
The chaperone-like activity of the wild-type and P39R mutant αB-crystallins was 
assessed by measuring the ability of these proteins to suppress the aggregation of 
denatured alcohol dehydrogenase (ADH) or insulin, essentially according to the 
previously reported methods [19,20].   ADH (0.8 mg/ml) was denatured in 50 mM 
Tris-HCl pH 8.0, 50 mM NaCl, and 10 mM EDTA at 37ºC, in the absence and presence 
of 0.8 mg/ml or 0.16 mg/ml of αB-crystallins.   Insulin (0.33 mg/ml) was denatured in 
50 mM Tris-HCl pH 8.0, 50 mM NaCl, and 10 mM DTT at 37ºC, in the absence and 
presence of 0.16 mg/ml or 0.08 mg/ml of αB-crystallins.   The aggregation of the 
target proteins was monitored by measuring light scattering at 360 nm as a function of 
time in a V-630 spectrophotometer (JASCO) equipped with a temperature-regulated cell 
holder. 
For the size-exclusion chromatography analyses, 8 mg/ml of ADH or 5 mg/ml of 
insulin was denatured in 50 mM Tris-HCl pH 8.0, 50 mM NaCl, and 30 mM EDTA or 
DTT at 37ºC, in the presence of 8 mg/ml of αB-crystallins.   Visibly large aggregates 
were removed by centrifuge before the samples were applied to the column. 
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Results and Discussion 
Circular dichroism spectral studies 
The secondary structures of the wild-type and P39R mutant αB-crystallins were 
determined by far-UV CD spectral analysis (Figure 2A and Table 1).   As expected, 
the mutation of Pro39 to Arg increased the α-helix content from 19.5% to 22.9%.   In 
contrast, the β-sheet content of the P39R mutant showed a reduction to 30.2%, reduced 
from 35.5% in the wild-type.   Few changes were observed in the β-turn and random 
coil contents.   Because the highly conserved core domain is very stable with a dimer 
of β-sandwiches [10,11,12] and the C-terminal domain is thought to be highly flexible, it 
is likely that the changes in the secondary structure contents observed in the CD spectral 
analyses were due solely to structural changes at the N-terminal domain of the P39R 
mutant αB-crystallin.   The predicted secondary structures of the N-terminal domain 
of wild-type αB-crystallin are composed of several helices and β-strands [15,16] (Figure 
1).   Therefore, it was assumed that the structural changes induced by the mutation at 
Pro39 to Arg are primarily limited to the N-terminal domain of αB-crystallin.   It has 
been reported that the conformation of the N-terminal domain is related to its 
oligomerization states [15,16], and that the deletion of the N-terminal domain results in a 
larger oligomer than that of the wild-type αB-crystallin [21].   Since the Pro residue 
generally acts as a structural disruptor in a regular α-helix, mutation at Pro39 to Arg 
contributes to increase α-helix content of the N-terminal domain of αB-crystallin. 
Molecular size analyses 
The molecular sizes of the oligomeric complexes of wild-type and P39R mutant 
αB-crystallins were estimated by size exclusion chromatography and DLS analyses.   
Size exclusion chromatography analysis revealed slightly faster elution for the P39R 
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mutant (calculated as ~620 kDa) than that of the wild-type αB-crystallin (calculated as 
~510 kDa, Figure 2B).   These results were confirmed by the DLS data.   The 
hydrodynamic radius of the wild-type and P39R mutant αB-crystallin was 8.0 and 8.3 
nm, respectively (Table 2).   These findings indicate that the conformational change at 
the N-terminal domain would lead to the formation of a larger assembly than that of the 
24-meric wild-type αB-crystallin.   This hypothesis does not contradict the assembly 
architecture proposed by Jehle et al., in which the N-terminal domain in the 24-mer 
model is located around the binding area for another molecule to form even larger 
oligomers, such as 26 or 28-mer oligomers[16].   The conformation of the N-terminal 
domain of P39R mutant αB-crystallin would be preferred to form a larger assembly than 
that of wild-type αB-crystallin. 
Chaperone-like activity 
The suppression of aggregation was analyzed for denatured ADH and insulin 
(Figure 3).   In the ADH assay, the addition of 0.8 mg/ml of wild-type or P39R mutant 
αB-crystallin reduced aggregation to 10.2% and 17.2% of the control, respectively, at 
2000 min.   Fewer αB-crystallins caused a weak suppression of aggregation; the 
addition of 0.16 mg/ml of wild-type or P39R mutant αB-crystallin reduced aggregation 
to 69.0% and 80.8% of the control level, respectively.   Thus, the P39R mutant 
displayed a slight loss of chaperone-like activity with respect to that of the wild-type 
αB-crystallin. 
In contrast, the P39R mutant showed a significant increase in chaperone-like 
activity in the insulin assay.   The addition of 0.16 mg/ml of wild-type or P39R mutant 
αB-crystallin reduced aggregation to 10.1% and 4.0% of the control level, respectively, 
at 2000 min.   Dilution by half of the wild-type αB-crystallin (0.08 mg/ml) resulted in 
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a much weaker suppression of aggregation, i.e., of 66.5% of the control, whereas 
dilution by half of the P39R mutant αB-crystallin retained to some extent of 
chaperone-like activity, i.e., of 20.7% of the control. 
To elucidate how complexes are formed in chaperone-like activity assays, size 
exclusion chromatography was performed under conditions similar to those used for the 
chaperone-like activity assays.   Protein concentrations were set to approximately ten 
times those used in the chaperone-like activity assays, in order to achieve clearer signals 
in the chromatograms and for subsequent PAGE analyses.   For the assays of ADH 
and wild-type αB-crystallin, very large aggregates were eluted at the void volume, but a 
large portion of the αB-crystallin was eluted at 15.4 ml, just prior to the elution volume 
(16.0 ml) of the control of wild-type αB-crystallin (Figure 4A).   The SDS-PAGE 
analysis of the void volume fraction demonstrated that the very large aggregates are 
derived from complexes of ADH and wild-type αB-crystallin, whereas the fraction at 
the highest peak contains primarily αB-crystallin and the fraction occurring just after the 
highest peak (shoulder peak at 17.0 ml) contains primarily ADH.   These observations 
indicate that a few very large complexes (>10 MDa) of ADH and wild-type 
αB-crystallin are formed, but that a large portion of the αB-crystallin binds to no 
substrates or to only a small amount of substrate.   Similar results were obtained in the 
assay of the ADH and P39R mutant αB-crystallin, except that the ratio of the peak of 
very large aggregates at the void volume to the main peak was reduced.   For the assay 
of insulin and wild-type αB-crystallin, very large aggregates were also eluted at the void 
volume, but the highest peak (13.6 ml) of elution volume was observed significantly 
before that of the control of wild-type αB-crystallin (Figure 4B).   The SDS-PAGE 
analysis demonstrated that both peaks are derived from complexes of insulin and 
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wild-type αB-crystallin.   Similar results were obtained for the assay of insulin and the 
P39R mutant αB-crystallin, except that the ratio of the peak of very large aggregates at 
the void volume to the main peak was significantly increased. 
The generation of the very large aggregates at the void volume corresponded to the 
observed chaperone-like activities.   Therefore, the chaperone-like activity of 
αB-crystallin would depend on how the very large aggregates, the molecular size of 
which was estimated at more than 10 MDa, were efficiently generated.   It has been 
previously reported that residues 57-69 and 93-107 are involved in the binding with 
denatured ADH[22].   Residues 57-69 are located at the end of the N-terminal domain.   
The conformational change at the N-terminal domain of the P39R mutant αB-crystallin 
would prevent residues 57-69 from interacting with denatured ADH, which would in 
turn suppress the formation of very large aggregates. 
There is currently no information about the binding site for denatured insulin, but 
the mechanism of interaction clearly differs between the αB-crystallin-ADH and 
αB-crystallin-insulin complexes.   In the insulin assay, most wild-type and P39R 
mutant αB-crystallins formed complexes of approximately 2,200-2,800 kDa, whereas 
these complexes were not observed in the ADH assay.   A major difference between 
the conditions used for the insulin and ADH assays was the molar ratio of the substrate 
proteins to αB-crystallins.   For the insulin assay, the molar ratios of the substrate 
protein to αB-crystallins were about 60 times higher than those of the ADH assay.   
Thus, complexes of approximately 2,200-2,800 kDa would have been responsible for 
the chaperone-like activity, in addition to the generation of very large aggregates at the 
void volume.    
In conclusion, the conformational changes in the N-terminal domain of 
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αB-crystallin induced by the mutation of Pro39 to Arg greatly affect the oligomerization 
and chaperone-like activity of αB-crystallin.   It has been reported that the N-terminal 
domain of αB-crystallin is primarily important for both its oligomerization and 
chaperone-like activity[21], and the hydrophobic region (residues 41-58) of the 
N-terminal domain is involved in the recognition of denatured proteins [23].   Our 
study demonstrated that the Pro39 is also a regulatory residue for the oligomerization 
and chaperone-like activity of αB-crystallin.   The Pro-rich environment at the 
N-terminal domain of αB-crystallin would allow for the diversity of conformations of 
the N-terminal domain and is expected to be responsible for both polydisperse 
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Figure 1.   Amino acid sequence alignment of the N-terminal domain of αB-crystallin 
with wheat HSP16.9 (wHSP16.9) and MjHSP16.5.   Pro residues are highlighted in 
boldface type.   The secondary structures proposed for αB-crystallin[16] and observed 
in the crystal structure of wheat HSP16.9[17] are indicated at the upper and lower sides 
of the alignment, respectively.   A gray background indicates the position of Pro39 of 
αB-crystallin. 
 
Figure 2.   (A) Far-UV CD spectra of wild-type and P39R mutant αB-crystallins.   
(B) Elution profiles of size exclusion chromatography for wild-type and P39R mutant 
αB-crystallins. 
 
Figure 3.   Chaperone-like activities of wild-type and P39R mutant αB-crystallins 
with (A) ADH (0.8 mg/ml) and (B) insulin (0.33 mg/ml) as substrate proteins at 37ºC. 
 
Figure 4.   Elution profiles and SDS-PAGE analyses of fractions of size exclusion 
chromatography for the complexes of (A) denatured ADH and (B) denatured insulin 
with wild-type and P39R mutant αB-crystallins.   The elution profiles of the control of 
wild-type and P39R mutant αB-crystallins are overlaid.   SDS-PAGE for the fraction 
of the void volume concentrated tenfold for the insulin and wild-type αB-crystallin 





A P39R mutation at the N-terminal domain of human αB-crystallin regulates its 
oligomeric state and chaperone-like activity 
 




Table 1.   Secondary structure contents (%) of wild-type and P39R mutant 
αB-crystallins. 
 α helix β sheet β turn Random coil 
Wild-type αB 19.5 35.5 18.8 26.2 




Table 2.   Hydrodynamic radius of wild-type and P39R mutant αB-crystallins. 
 Rh (nm) Cp/Rh (%) 
Wild-type αB 8.0 14.5 
P39R 8.3 18.3 
Rh, hydrodynamic radius 
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